Jersey Urology Group

What Jersey Urology Group does

Jersey Urology Group is a privately held, physician-owned urology medical practice founded in 2007 by Dr. Michael J. Schutz along with Drs. Wren and Piskun, operating two office locations in Somers Point and Galloway, New Jersey, with surgical privileges at Shore Medical Center. The practice serves men and women across southern New Jersey with a comprehensive urology service portfolio covering kidney stones, benign prostatic hyperplasia (BPH), erectile dysfunction, overactive bladder, urinary incontinence, male infertility, vasectomy and vasectomy reversal, and testosterone optimization. Service delivery spans office-based consultations, in-office procedures, and hospital-based surgery including robotic, laparoscopic, and endoscopic operations.

The practice operates a broad procedural and diagnostic technology stack, including AIUM-accredited ultrasound services performed by certified technologists and board-certified urologists, no-scalpel vasectomy, and FDA-approved minimally invasive therapies such as Rezum water vapor therapy, Urolift implants, Prostate Artery Embolization (PAE) delivered through a partnership with interventional radiology (Dr. Joel Wolf and NJPAE), InterStim sacral neuromodulation under a Medtronic partnership, BOTOX bladder injection, and Xiaflex injections for Peyronie's Disease. Diagnostic and treatment capabilities are reinforced by American Institute of Ultrasound in Medicine (AIUM) accreditation, held by only a few practices in New Jersey.

The business model is fee-for-service clinical care billed primarily through Medicare, Medicaid, and private insurance, with supplementary self-pay options for treatments such as testosterone replacement therapy that are often considered elective. The go-to-market motion is direct-to-consumer: the practice acquires patients through its website, local SEO, online testimonials, and next-day appointment availability positioned against months-long wait times at competing regional urology practices. Patient engagement is supported by Phreesia online self-scheduling, MyHealthRecord patient portal, and an integrated Labcorp scheduling workflow. The clinical team comprises eight physicians with subspecialty training (including robotics, endourology, oncology, and voiding dysfunction) and five physician assistants. Multiple physicians hold repeated Top Doctor recognitions from Philadelphia Magazine, Connecticut/Hartford Magazine, and NJ Monthly, with no external private equity or venture capital ownership evidenced in the source data.

Name

Jersey Urology Group

Legal name

Jersey Urology Group

Website

https://jerseyurology.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Jersey Urology Group is a physician-owned urology practice in southern New Jersey offering comprehensive medical and surgical urological care for men and women, including kidney stone treatment, BPH, erectile dysfunction, infertility, and minimally invasive procedures across two office locations and Shore Medical Center.

Ownership category

akta.pro rank

Product category

Urology Healthcare Services

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

General Urology (HLAKAOAA)

akta.pro secondary industries

Urologic Oncology (HLAKAOAB), Endourology & Minimally Invasive Urologic Surgery (HLAKAOAF), Urolithiasis / Kidney Stone Centers (HLAKAOAG), Urogynecology & Pelvic Reconstructive Surgery (Female Pelvic Medicine) (HLAKAJAE)

Keywords

• Urology medical practice
• Urological surgical services
• Prostate disease treatment
• Bladder dysfunction care
• Men's health treatment

Headquarters

HQ city

Somers Point

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Patient Services: Direct patient care services billed through insurance including office visits, procedures, and surgeries. Revenue generated from consultation fees, diagnostic services, and treatment procedures covered by Medicare, Medicaid, and private insurance.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Jersey Urology Group is a physician-owned urology medical practice providing diagnostic, medical, and surgical treatment for the full spectrum of male and female urological conditions. Services include kidney stone management, BPH treatment (Rezum, Urolift, PAE), erectile dysfunction care, OAB/voiding dysfunction therapies (BOTOX, InterStim), vasectomy, infertility treatment, ultrasound diagnostics, and a testosterone optimization program, delivered across two southern New Jersey offices with next-day appointment availability.

Product overview

Jersey Urology Group is a urology practice offering a comprehensive portfolio of medical and surgical services for male and female urologic conditions. The practice provides diagnostic services (ultrasound with AIUM accreditation), medical treatments (Testosterone Optimization Program, OAB medications, BPH medications), and surgical procedures. Surgical offerings include minimally invasive BPH treatments (Rezum, Urolift, PAE), kidney stone management (shockwave, ureteroscopy), infertility services (vasectomy reversal, varicocelectomy), erectile dysfunction treatments including Xiaflex for Peyronie's Disease, vasectomy, and advanced bladder therapies (BOTOX, InterStim neuromodulation). The practice operates two locations in southern New Jersey with next-day appointment availability.

Differentiator

Problem solved

Functional benefit

Products and services

• Prostate Artery Embolization (PAE) Minimally invasive image-guided procedure that reduces blood flow to the prostate to treat urinary symptoms from BPH, performed by an interventional radiologist through a small wrist or groin incision.
• Kidney Stones Treatment Minimally invasive removal of kidney stones including shockwave treatment and ureteroscopy, plus metabolic evaluation and prevention programs to reduce recurrence.
• Rezum Water Vapor Therapy FDA-approved, non-surgical BPH treatment using steam energy to remove excess prostate tissue pressing on the urethra; office-based procedure that preserves sexual function.
• Urolift FDA-approved, minimally invasive BPH procedure using tiny implants to hold open the obstructed urine pathway; in-office, no heating, cutting, or tissue removal, and preserves sexual function.
• Xiaflex for Peyronie's Disease FDA-approved injectable treatment for men with Peyronie's Disease and penile curvature of 30 degrees or greater, breaking down scar tissue over time.
• Erectile Dysfunction Treatment Diagnosis and treatment of erectile dysfunction, identifying underlying causes such as decreased blood flow, nerve damage, and systemic illness.
• Vasectomy Permanent surgical contraception cutting and cauterizing scrotal tubes; offered as no-scalpel and traditional techniques with nearly 100% effectiveness.
• Vasectomy Reversal Reconnection of the vas deferens for men with prior vasectomy wishing to restore fertility; pregnancy rates range from 30% to 90% depending on time since vasectomy and other factors.
• Varicocelectomy Surgical removal of varicoceles (swollen scrotal veins) that can cause male-factor infertility; restores normal blood flow to improve sperm parameters.
• Infertility Treatments Male infertility evaluation and treatment including semen analysis, hormone labs, medications, specialist referrals, and surgical interventions.
• BOTOX Bladder Injection BOTOX injection into the bladder for overactive bladder and urge incontinence; outpatient procedure with effects lasting approximately 6 months, covered by Medicare/Medicaid and many private insurances.
• InterStim Sacral Neuromodulation FDA-approved implantable device delivering mild electrical impulses to sacral nerves to treat overactive bladder and non-obstructive urinary retention; MRI compatible with recharge-free and rechargeable options.
• Ultrasound Services Accredited ultrasound diagnostics by certified technologists and board-certified urologists for kidney, bladder, prostate, scrotal, testicular issues, and erectile dysfunction evaluation.
• Testosterone Optimization Program Physician-directed testosterone replacement therapy including injections, oral Kyzatrex, and pellet implants for men with low testosterone symptoms.
• OAB and Voiding Dysfunction Treatment Diagnosis and treatment of overactive bladder and urinary incontinence including lifestyle changes, medications, BOTOX, and InterStim therapy.
• BPH / Enlarged Prostate Treatment Comprehensive BPH management including medications, Rezum, Urolift, and PAE for lower urinary tract symptoms caused by prostate enlargement.

Named customers2 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature7 records

Partnerships

Four partnerships are on record, tiered core.

• Dr. Joel Wolf (Interventional Radiologist)coreTechnology or IntegrationDr. Joel Wolf is a board-certified interventional radiologist who performs Prostate Artery Embolization (PAE) procedures in collaboration with Jersey Urology Group. He completed medical school at University of Pittsburgh School of Medicine in 2015, followed by diagnostic radiology residency at Albert Einstein College of Medicine's Jacobi Medical Center and fellowship in interventional radiology at Montefiore Medical Center.
• NJPAE (New Jersey Prostate Artery Embolization)coreTechnology or IntegrationNJPAE team offers specialized Prostate Artery Embolization procedure in collaboration with Jersey Urology Group, providing advanced minimally invasive treatment for enlarged prostate.
• Shore Medical CentercoreOthersJersey Urology Group performs surgical procedures at Shore Medical Center in Somers Point, NJ. Dr. Gjertson provides robotic, open, and endoscopic surgery options at this facility. The practice also started the Prostate program at Shore Medical Center in 2018.
• MedtroniccoreTechnology or IntegrationJersey Urology Group offers Medtronic InterStim systems for bladder control therapy, an FDA approved treatment for overactive bladder and non-obstructive urinary retention. The practice provides evaluation, implantation, and ongoing management of this device therapy.

Scale indicators1 record

Recent moves6 records

Expansion highlights6 records

Direct peers

• New Jersey Urology: Largest independent urology group practice in New Jersey with multiple offices across the state, treating the full spectrum of urologic conditions. Direct competitor in the same geographic market, operating a similar multi-site, multi-physician urology specialty model.
• Georgia Urology: Multi-location urology specialty practice in the Southeast offering comprehensive adult urology services including oncology, robotics, kidney stones, and incontinence. Closely comparable as a multi-site, multi-subspecialist independent urology group.
• Chesapeake Urology: Large Mid-Atlantic urology practice (now part of U.S. Urology Partners) with a similarly broad urology service line including oncology, female urology, infertility, and BPH. Comparable in scale, service breadth, and multi-site physician-owned origin story.
• Adult & Pediatric Urology: Independent multi-physician urology group serving the Twin Cities and western Wisconsin, providing comparable medical and surgical urology services across BPH, oncology, stone disease, and incontinence. Mirrors the same private-practice clinical model.
• Michigan Institute of Urology: Large single-specialty urology group in Michigan with subspecialists across oncology, robotic surgery, and reconstruction. Directly comparable as a multi-site independent urology practice of similar scale and clinical scope.

Others

• Medtronic: Manufacturer of the InterStim sacral neuromodulation system offered in-office by Jersey Urology. Relevant as a key device partner whose commercial terms and product roadmap directly influence the practice's advanced procedure economics.
• Shore Medical Center: Community hospital in Somers Point, NJ where Jersey Urology's physicians perform inpatient and outpatient surgical cases. Comparable as a partner institution in the local care delivery ecosystem rather than a direct competitor.

Broad incumbents

• U.S. Urology Partners: Private-equity-backed platform aggregating urology practices including Chesapeake Urology, with capital and scale advantages. Relevant as the dominant consolidator reshaping the same competitive set Jersey Urology operates in.

Regional players

• Hackensack Meridian Health: Largest New Jersey hospital system with employed urologists and outpatient urology programs across the state. Relevant as a regional competitor and potential acquirer/partner for urology specialty services in NJ.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/jersey-urology-group

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jersey Urology Group